Patient & Parent Support
If you are a healthcare professional affiliated with an employer, institution or
committee, or practicing in a state, that restricts what items you may receive from
manufacturers, we ask that you not accept or download any restricted items from
this site. If you are a healthcare provider practicing in Vermont, we are required
by state law to deny you permission to download any items or review any journal
articles made available on this site.
Created for parents and caregivers, www.pulmicortrespules.com
can help caregivers understand asthma and PULMICORT RESPULES after they’ve
left your office. Some key themes include stressing the need for ongoing control, help
using a jet nebulizer,
and how to recognize asthma symptoms.
Also, see some of the key information PULMICORT RESPULES provides for parents and
caregivers to help keep their child’s persistent asthma symptoms under control.
And learn about the variety of online resources and tools that are available for
parents and caregivers.
To introduce parents and patients to the jet nebulizer, share with them the
Mom’s Guide to Jet Nebulizing. It contains information about the device,
how to use it, and how to clean it.
Download
You can also prepare patients and caregivers with a plan for maintaining control
of asthma symptoms by sharing the
Discussion Guide and Asthma Action Plan
with them.
Some files on this page require Adobe® Reader® to be installed. If you do not have Adobe Reader
on your computer, you can download it here.
IMPORTANT SAFETY INFORMATION ABOUT PULMICORT
RESPULES
PULMICORT RESPULES is not a bronchodilator and is NOT indicated for the relief of
acute bronchospasm.
Particular care is needed for patients who are transferred from systemically active
corticosteroids to PULMICORT RESPULES, because deaths due to adrenal insufficiency
have occurred in asthmatic patients during and after transfer from systemic corticosteroids
to less systemically available inhaled corticosteroids.
It is possible that systemic corticosteroid effects such as hypercorticism, reduced
bone mineral density, and adrenal suppression may appear in a small number of patients,
particularly at higher doses.
Patients taking immunosuppressant doses of corticosteroids should avoid exposure
to infections such as chicken pox and measles.
Inhaled corticosteroids may cause a reduction in growth velocity. The long-term
effect on final adult height is unknown.
Hypersensitivity reactions, including anaphylaxis, have been reported with budesonide.
As with other inhaled medications, paradoxical bronchospasm may occur with
PULMICORT
RESPULES.
In rare cases, patients on inhaled corticosteroids may present with systemic eosinophilic
conditions and clinical features consistent with Churg-Strauss Syndrome.
Adverse reactions that occurred at a rate of ≥ 3% are: respiratory infection, rhinitis, coughing, otitis media, viral infection, moniliasis, gastroenteritis, vomiting, diarrhea, abdominal pain, ear infection, epistaxis, conjunctivitis, and rash.
Indication
PULMICORT RESPULES (budesonide inhalation suspension) is indicated for the maintenance
treatment of asthma and as prophylactic therapy in children ages 12 months to 8 years.
Please
click
here
for full Prescribing Information for PULMICORT RESPULES.